Associations have been documented recently between some of the 23 single nucleotide polymorphisms newly discovered with the Collaborative Oncological Gene-environment Study iCOGS array that indicate prostate cancer (PCa) risk and aspects of disease aggressiveness.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The utility of these iCOGS SNPs remains to be determined in active surveillance (AS).
To determine associations between iCOGS SNPs and upgrading among men who underwent surgical treatment and AS for low-risk PCa.
The genotypes of the 23 iCOGS SNPs were determined for all white subjects with biopsy Gleason score (GS) 6 including 950 men who underwent definitive treatment with surgery and 209 men who elected AS. The clinical and pathologic characteristics were documented for all subjects.
Men who underwent surgery were grouped according to their pathologic GS (upgraded was defined as GS ≥7; nonupgraded remained GS 6). Men who were enrolled in AS were also grouped according to their GS on subsequent surveillance biopsies. Statistical analyses were performed comparing the genotypes between the upgraded and nonupgraded groups.
Overall, 31% and 34% of men were upgraded in the surgery and AS cohorts, respectively. Three iCOGS SNPs were significantly associated with the risk of upgrading in the surgical cohort. After correction for multiple testing, only rs11568818 on chromosome 11q22 remained significantly associated with upgrading. Assessment of this allele in the AS cohort reveals that it was present at noteworthy higher frequencies in men with high-grade disease on surveillance biopsies compared with nonupgraded men (p=0. 003). This study was primarily limited by the homogeneous patient population.
This is the first report of a SNP on chromosome 11q22 associated with higher grade disease in a surgical cohort that is also validated for eventual upgrading in a prospective AS cohort.
We examined the relationship between a group of genetic markers and prostate cancer (PCa) aggressiveness in a group of patients who underwent surgery for PCa and a group of patients who were enrolled in active surveillance. We found that these genetic markers helped predict which patients had more aggressive disease in both groups.
European urology. 2015 Sep 24 [Epub ahead of print]
James T Kearns, Brittany Lapin, Edward Wang, Kimberly A Roehl, Phillip Cooper, William J Catalona, Brian T Helfand
Section of Urology, University of Chicago, Chicago, IL, USA. Division of Urology, NorthShore University Health System, Evanston, IL, USA. , Division of Urology, NorthShore University Health System, Evanston, IL, USA. , Department of Urology, Northwestern University, Chicago, IL, USA. , Department of Urology, Northwestern University, Chicago, IL, USA. , Department of Urology, Northwestern University, Chicago, IL, USA. , Division of Urology, NorthShore University Health System, Evanston, IL, USA.